HBP.TO
Helix Biopharma Corp
Price:  
0.24 
CAD
Volume:  
30,860.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBP.TO WACC - Weighted Average Cost of Capital

The WACC of Helix Biopharma Corp (HBP.TO) is 7.4%.

The Cost of Equity of Helix Biopharma Corp (HBP.TO) is 11.15%.
The Cost of Debt of Helix Biopharma Corp (HBP.TO) is 5.00%.

Range Selected
Cost of equity 9.10% - 13.20% 11.15%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.4% - 8.4% 7.4%
WACC

HBP.TO WACC calculation

Category Low High
Long-term bond rate 3.3% 3.8%
Equity market risk premium 5.1% 6.1%
Adjusted beta 1.15 1.46
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.10% 13.20%
Tax rate 25.90% 26.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.4% 8.4%
Selected WACC 7.4%